$3.88 Billion is the total value of SCOPIA CAPITAL MANAGEMENT LP's 36 reported holdings in Q2 2014. The portfolio turnover from Q1 2014 to Q2 2014 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
PHH | Exit | PHH CORP | $0 | – | -292,129 | -100.0% | -0.24% | – |
ARX | Exit | AEROFLEX HLDG CORP | $0 | – | -1,836,672 | -100.0% | -0.48% | – |
DDD | Exit | 3-D SYS CORP DELput | $0 | – | -536,000 | -100.0% | -1.00% | – |
T104PS | Exit | AMERICAN RLTY CAP PPTYS INC | $0 | – | -2,627,569 | -100.0% | -1.17% | – |
GRA | Exit | GRACE W R & CO DEL NEWput | $0 | – | -534,900 | -100.0% | -1.68% | – |
BIDU | Exit | BAIDU INCput | $0 | – | -457,400 | -100.0% | -2.21% | – |
RHP | Exit | RYMAN HOSPITALITY PPTYS INC | $0 | – | -1,992,539 | -100.0% | -2.69% | – |
GEO | Exit | GEO GROUP INC | $0 | – | -2,710,236 | -100.0% | -2.77% | – |
PRGO | Exit | PERRIGO CO PLC | $0 | – | -743,067 | -100.0% | -3.64% | – |
FAST | Exit | FASTENAL COput | $0 | – | -2,498,200 | -100.0% | -3.90% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-08-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
SPIRIT AEROSYSTEMS HLDGS INC | 39 | Q4 2022 | 28.3% |
SPDR S&P 500 ETF TR | 31 | Q3 2023 | 16.9% |
ISHARES TR | 28 | Q3 2023 | 10.9% |
MANNKIND CORP | 24 | Q3 2023 | 0.5% |
BAIDU INC | 21 | Q2 2018 | 8.6% |
ITRON INC | 21 | Q3 2020 | 12.1% |
RETROPHIN INC | 20 | Q3 2020 | 4.5% |
HARMONIC INC | 19 | Q3 2023 | 10.5% |
JOHNSON CTLS INTL PLC | 17 | Q3 2020 | 9.6% |
ACORDA THERAPEUTICS INC | 17 | Q3 2019 | 4.0% |
View SCOPIA CAPITAL MANAGEMENT LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
VERRA MOBILITY Corp | October 28, 2022 | 6,710,074 | 4.4% |
Spirit AeroSystems Holdings, Inc. | February 14, 2022 | 2,084,212 | 2.0% |
Retrophin, Inc. | February 14, 2020 | 2,011,697 | 4.7% |
Horizon Therapeutics Public Ltd Co | January 10, 2020 | 2,527,456 | 1.4% |
ZOGENIX, INC. | January 10, 2020 | 919,484 | 2.1% |
ITRON, INC. | January 07, 2020 | 1,808,059 | 4.6% |
ACORDA THERAPEUTICS INCSold out | November 12, 2019 | 0 | 0.0% |
LA JOLLA PHARMACEUTICAL CO | April 10, 2019 | 480,000 | 1.8% |
Prothena Corp plc | March 11, 2019 | 1,883,816 | 4.7% |
GW PHARMACEUTICALS PLC | February 14, 2019 | 1,345,198 | 4.6% |
View SCOPIA CAPITAL MANAGEMENT LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13D | 2024-04-26 |
13F-HR | 2024-02-14 |
SC 13G | 2024-02-14 |
SC 13D/A | 2024-01-22 |
13F-HR/A | 2023-11-14 |
13F-HR | 2023-11-14 |
SC 13D | 2023-09-21 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
SC 13D/A | 2023-04-12 |
View SCOPIA CAPITAL MANAGEMENT LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.